Most Recent
The applicants in class actions over alleged engine defects in Hyundai and Kia vehicles can file amended cases, over the objections of the car makers, which claim the new pleadings are "worse" despite millions of dollars having been spent on discovery.
A judge has allowed a "painfully slow" competition class action against Sony over its PlayStation store practices to file an amended pleading, after expressing concerns the case was not properly resourced.
A class action accusing Sony of breaching competition laws has said proposed changes to the case will focus on excessive charges in the distribution market, but the electronics giant argues the amended case leaves causation "entirely unarticulated".
Three years after filing, the class actions against Hyundai and Kia are trying to pinpoint the defect at the heart of the cases, with the car manufacturers complaining that the newest pleading, which seeks to expand the claims to include an additional 380,000 vehicles, is still missing key details.
Construction PRO
A deed of company arrangement for three companies associated with developer Descon-Adcon has fallen apart after former boss Danny Isaac failed to make a $5 million contribution required under the rescue plan.
Meal delivery companies Hello Fresh and Youfoodz say the consumer regulator needs to provide more details in its cases alleging customers were charged a fee after cancelling subscriptions.
Construction PRO
The developers of the Aspen and Establishment residential projects in Canberra have flagged they may expand their $13 million cross-claims against builder Geocon to include defects claims.
A Federal Court suit by HR company Employment Hero accusing investor and rival Seek of misusing its market power has been resolved.
ASIC has questions about the “bona fides” of a rental company’s appeal of a $7.4 million penalty for unlawful loan agreements, telling a court it needs to see evidence about the “very rapid decline” of the company’s financial position.
German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled.